Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures +1.04%, Hang Seng Futures +0.21%, ASX SPI 200 +1.28%, S&P Futures +0.01%

Nov 25 ,2025

  • Synopsis:

    • Asia equities poised for a firmer open Wednesday. Futures in Japan, Hong Kong, South Korea and Australia were all higher. Almost all Japan ADRs were higher while Golden Dragon China index rose 0.35%. US benchmarks broadly advanced overnight in a strong finish to the session and futures maintaining gains. Tech leads were positive (more in terms of breadth than magnitude) with SOX index up a moderate 0.16% and US big tech broadly higher. Treasuries were firmer with a bit of curve steepening. Dollar index was down 0.3%. Gold finished up 1.1%. Bitcoin futures were down 2.0% after a 5%+ rally on Monday. WTI crude settled down 1.5% on volatile Ukraine peace-deal headlines.

    • Symbiotic Fed rate cut expectations and tech strength were the main themes. Sentiment encouraged again by revival in rate cut expectations as latest dovish Fedspeak was reinforced by somewhat soft macro data. Also, press reported Hassett has emerged as the front runner to replace Powell as Fed chair, offering additional dovish implications. Alphabet (GOOGL) shares rose sharply after yesterday's report about how it may make its custom-designed TPU chips broadly available to Google Cloud customers. Meta (META) was the best performer among Mag 7 on a report they may use Google AI chips. Nvidia (NVDA) was the lone decliner reflecting competitive implications. Well-received Gemini 3 launch also seen as a potential threat to OpenAI in which SoftBank (9984.JP) is highly exposed. Broader market trading conviction apt to lighten toward the US Thanksgiving holiday.

    • Asia themes remain largely focused on better US-China headlines in the absence of other major catalysts. Treasury Secretary Bessent maintained positive rhetoric, noting China "right on schedule" in terms of US soybean purchases. Added Trump and Xi may meet four times next year that will serve to maintain stability in bilateral relations. Geopolitics remain a risk with Taiwan the most sensitive issue for Beijing, provoked by Japan PM Takaichi's recent remarks. US stance unchanged while also reassuring Tokyo with support. Yen weakness another key focus, stimulating elevated conjecture on how this raises the chances of a BOJ rate hike. Japan remains the outlier in the region as other central banks continue to lean dovish. Upcoming events include RBNZ meeting today expected to deliver a 25 bp rate cut, followed by BOK tomorrow seen on hold for now. On data, Australia monthly CPI to attract attention after latest readings wiped out near-term expectations for an RBA rate cut.

  • Pre-open Company News:

    • 9666.HK -- Boyu Group extends offer for Jinke Smart Services Group to 26-Jan

    • A7RU.SP -- Keppel Infrastructure Trust completes acquisition of 46.7% stake in Global Marine Group; deal was announced on 1-Apr

    • 2582.HK -- Jiangsu Guofu Hydrogen Energy Equipment to place up to 4.9M new H-shares at HK$41.166/share

    • 4578.JP -- FDA approves Voyxact (sibeprenlimab) for adults with IgAN

    • 601118.CH -- China Hainan Rubber Industry Group controlling shareholder Hainan State Farms Investment to issue CNY2.1B exchangeable bonds

    • US proxy advisor backlash; EIB green finance eligibility tool; Bloomberg transition risk analytics among ESG products & ratings highlights Oct-Nov

    • 500294.IN -- NCC receives INR20.63B contract from Assam's Public Works Department

    • 524230.IN -- Ministry of Chemicals & Fertilizers entrusts additional charge of CMD of Rashtriya Chemicals and Fertilizers to director (finance) Nazhat Shaikh for six months, effective 1-Jan-26

    • 300144.CH -- Songcheng Performance Development acquires Hangzhou Songcheng Industry from controlling shareholder for CNY963.0M cash

    • Y92.SP -- Thai Beverage Public reports FY net income attributable THB25.36B vs FactSet THB28.32B [9 est, THB25.32-30.89B]

    • 000977.CH -- IEIT Systems Co. completes CNY200-300M share buyback announced on 9-Jul

    • 688516.CH -- Wuxi Autowell Technology obtains CNY700M equipment sales contract

    • 603056.CH -- Deppon Logistics completes 30.0M shares purchase totaling CNY417.8M by controlling shareholder JD.com

    • 2887.TT -- Taishin Shin Kong Financial Holdings receives Financial Supervisory Commission approval for Taishin-Shin Kong merger

  • On Deck:

    • China:

      • Economic:

        • 08:00 CST: Foreign Direct Investment Y/Y; consensus

    • Hong Kong:

      • Earnings:

        • Envision Greenwise Holdings (1783.HK), China Dongxiang (Group) (3818.HK), Alibaba Health Information Technology (241.HK), China Education Group Holdings (839.HK)

    • Japan:

      • Economic:

        • 14:00 JST: Leading Index (Final); consensus

    • New Zealand:

      • Earnings:

        • Ryman Healthcare (RYM.NZ), Tower (TWR.NZ)

    • Malaysia:

      • Earnings:

        • Petronas Dagangan (5681.MK)

  • Market Data:

    • Gold (Dec 25): ($9.90) or (0.24%) to $4130.10

    • WTI Crude (Jan 26): +$0.12 or +0.21% to $58.07

    • $-¥: (0.78) or (0.50%) to 156.1370

    • $-KRW: (9.74) or (0.66%) to 1464.9300

    • A$-$: +0.00 or +0.05% to 0.6466

    • $-INR: +0.01 or +0.01% to 89.1516

    • $-CNY: (0.02) or (0.27%) to 7.0837

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE